Other
Increase (Decrease) in Contract with Customer, Asset
West Pharmaceutical Services Increase (Decrease) in Contract with Customer, Asset increased by 66.7% to $3.50M in Q1 2026 compared to the prior quarter.
Analysis
StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2024
Last reportedQ1 2026Apr 23, 2026
How to read this metric
An increase often signals aggressive customer acquisition efforts, while a decrease may indicate a shift in sales strategy or amortization of existing contract assets.
Detailed definition
The net change in assets recognized for the costs of obtaining or fulfilling a contract with a customer that are expecte...
Peer comparison
Common in subscription-based industries like telecommunications and software.
Metric ID:
other_increase_decrease_in_contract_with_customer_assetHistorical Data
4 periods
| Q3 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $19.70M | $2.50M | $2.10M | $3.50M |
| QoQ Change | — | -87.3% | -16.0% | +66.7% |
| YoY Change | — | — | — | +40.0% |
Range$2.10M – $19.70M
Avg YoY Growth+40.0%
Median YoY Growth+40.0%
Increase (Decrease) in Contract with Customer, Asset at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's increase (decrease) in contract with customer, asset?
- West Pharmaceutical Services (WST) reported increase (decrease) in contract with customer, asset of $3.50M in Q1 2026.
- What does increase (decrease) in contract with customer, asset mean?
- The net change in capitalized costs associated with acquiring or fulfilling customer contracts.